---
title: "This Cue Biopharma Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/299444479.md"
description: "Wall Street analysts initiated bullish coverage on five stocks: TRAX, BGSI, NPCE, CUE, and NGVC. Evercore ISI rated TRAX Outperform with a $65 target; Mizuho rated BGSI Outperform at $120; Keybanc rated NPCE Overweight at $18; B. Riley rated CUE Buy at $83; and BofA rated NGVC Buy at $35."
datetime: "2026-09-18T11:53:05.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/299444479.md)
  - [en](https://longbridge.com/en/news/299444479.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/299444479.md)
generator: "portal-rs"
---

# This Cue Biopharma Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

-   Evercore ISI Group initiated coverage on **First Tracks Biotherapeutics Inc** (NASDAQ:TRAX) with an Outperform rating and announced a price target of $65. First Tracks closed at $39.20 on Thursday. See how other analysts view this stock.
-   Mizuho analyst David Bellinger initiated coverage on **Boyd Group Services Inc** (NYSE:BGSI) with an Outperform rating and announced a price target of $120. Boyd Group shares closed at $81.00 on Thursday. See how other analysts view this stock.
-   Keybanc analyst Brett Fishbin initiated coverage on **Neuropace Inc** (NASDAQ:NPCE) with an Overweight rating and announced a price target of $18. NeuroPace closed at $14.15 on Thursday. See how other analysts view this stock.
-   B. Riley Securities analyst Mayank Mamtani initiated coverage on **Cue Biopharma Inc** (NASDAQ:CUE) with a Buy rating and announced a price target of $83. Cue Biopharma shares closed at $37.84 on Thursday. See how other analysts view this stock.
-   B of A Securities analyst Vicky Liu initiated coverage on **Natural Grocers by Vitamin Cottage Inc** (NYSE:NGVC) with a Buy rating and announced a price target of $35. Natural Grocers closed at $29.32 on Thursday. See how other analysts view this stock.

Considering buying CUE stock? Here’s what analysts think:

*Photo via Shutterstock*

### Related Stocks

- [BGSI.US](https://longbridge.com/en/quote/BGSI.US.md)
- [CUE.US](https://longbridge.com/en/quote/CUE.US.md)
- [NGVC.US](https://longbridge.com/en/quote/NGVC.US.md)
- [TRAX.US](https://longbridge.com/en/quote/TRAX.US.md)
- [NPCE.US](https://longbridge.com/en/quote/NPCE.US.md)

## Related News & Research

- [Boyd Group Services (TSE:BYD) Insider Purchases C$38,909.50 in Stock](https://longbridge.com/en/news/300475554.md)
- [Cue Biopharma’s CUE-221 Hits Phase II Goals, Shows Durable CSU Response](https://longbridge.com/en/news/300278073.md)
- [BUZZ-Cue Biopharma surges after positive results from mid-stage study for CUE-221](https://longbridge.com/en/news/299619038.md)
- [Natural Grocers by Vitamin Cottage, Inc. (NYSE:NGVC) Given Average Recommendation of "Moderate Buy" by Analysts](https://longbridge.com/en/news/299879091.md)
- [CUE: CUE-221 achieved significant efficacy and safety in Phase 2 CSU, outperforming omalizumab](https://longbridge.com/en/news/299604705.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**